Radiotherapy for 41 patients with stages I and II MALT lymphoma: A retrospective study

Radiotherapy and Oncology

Volumn 87, Issue 3, 2008, Pages 412-417

  Yamashita, Hideomi ^a   Nakagawa, Keiichi ^a   Asari, Takao ^a   Murakami, Naoya ^a   Igaki, Hiroshi ^a   Ohtomo, Kuni ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

MALT; Non Hodgkin's lymphoma; Radiation therapy; Treatment

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CATARACT; CLINICAL ARTICLE; CONJUNCTIVITIS; CONTROLLED STUDY; DERMATITIS; DISEASE FREE SURVIVAL; EDEMA; ERADICATION THERAPY; FEMALE; FOLLOW UP; HUMAN; INTESTINE OBSTRUCTION; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PANCREATITIS; PRIORITY JOURNAL; RADIATION DOSE; SEX RATIO; ULCER;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; RADIATION INJURIES; RADIOTHERAPY DOSAGE;

EID: 46549087709     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.03.012     Document Type: Article

References (53)

1. Harris N.L., Jaffe E.S., Stein H., Banks P.M., Chan J.K., Cleary M.L., et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84 (1994) 1361-1392
2. Harris N.L., Jaffe E.S., Diebold J., Flandrin G., Muller-Hermelink H.K., Vardiman J., et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting - Airlie House, Virginia, November 1997. J Clin Oncol 17 (1999) 3835-3849
3. Armitage J.O., and Weisenburger D.D. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol 16 (1998) 2780-2795
4. Anderson J.R., Armitage J.O., and Weisenburger D.D. Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 9 (1998) 717-720
5. Lymphoma Study Group of Japanese Pathologists: The World Health Organization classification of malignant lymphomas in Japan: incidence of recently recognized entities. Pathol Int 2000;50:696-702.
6. Bayerdörffer E., Neubauer A., Rudolph B., Thiede C., Lehn N., Eidt S., et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet 345 (1995) 1591-1594
7. Roggero E., Zucca E., Pinotti G., Pascarella A., Capella C., Savio A., et al. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med 122 (1995) 767-769
8. Steinbach G., Ford R., Glober G., Sample D., Hagemeister F.B., Lynch P.M., et al. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med 131 (1999) 88-95
9. Isaacson P.G., Diss T.C., Wotherspoon A.C., Barbazza R., De Boni M., and Doglioni C. Long-term follow-up of gastric MALT lymphoma treated by eradication of H. pylori with antibodies. Gastroenterology 117 (1999) 750-751
10. Savio A., Zamboni G., Capelli P., Negrini R., Santandrea G., Scarpa A., et al. Relapse of low-grade gastric MALT lymphoma after Helicobacter pylori eradication: true relapse or persistence? Long-term post-treatment follow-up of a multicenter trial in the north-east of Italy and evaluation of the diagnostic protocol's adequacy. Recent Results Cancer Res 156 (2000) 116-124
11. Aozasa K. Hashimoto's thyroiditis as a risk factor of thyroid lymphoma. Acta Pathol Jpn 40 (1990) 459-468
12. Tzioufas A.G., Boumba D.S., Skopouli F.N., and Moutsopoulos H.M. Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndrome. Arthritis Rheum 39 (1996) 767-772
13. Thieblemont C., Bastion Y., Berger F., Rieux C., Salles G., Dumontet C., et al. Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients. J Clin Oncol 15 (1997) 1624-1630
14. Zucca E., Roggero E., and Pileri S. B-cell lymphoma of MALT type: a review with special emphasis on diagnostic and management problems of low-grade gastric tumours. Br J Haematol 100 (1998) 3-14
15. Chao C.K., Lin H.S., Devineni V.R., et al. Radiation therapy for primary orbital lymphoma. Int J Radiat Oncol Biol Phys 31 (1995) 929-934
16. Bolek T.W., Moyses H.M., Marcus Jr. R.B., et al. Radiotherapy in the management of orbital lymphoma. Int J Radiat Oncol Biol Phys 44 (1999) 31-36
17. Pelloski C.E., Wilder R.B., Ha C.S., et al. Clinical stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatment. Radiother Oncol 59 (2001) 145-151
18. Stafford S.L., Kozelsky T.F., Garrity J.A., et al. Orbital lymphoma: radiotherapy outcome and complications. Radiother Oncol 59 (2001) 139-144
19. Le Q.T., Eulau S.M., George T.I., et al. Primary radiotherapy for localized orbital MALT lymphoma. Int J Radiat Oncol Biol Phys 52 (2002) 657-663
20. Fung C.Y., Tarbell N.J., Lucarelli M.J., et al. Ocular adnexal lymphoma: clinical behavior of distinct world health organization classification subtypes. Int J Radiat Oncol Biol Phys 57 (2003) 1382-1391
21. Hasegawa M., Kojima M., Shioya M., et al. Treatment results of radiotherapy for malignant lymphoma of the orbit and histopathologic review according to the WHO classification. Int J Radiat Oncol Biol Phys 57 (2003) 172-176
22. Martinet S., Ozsahin M., Belkacemi Y., et al. Outcome and prognostic factor in orbital lymphoma: a rare cancer network study on 90 consecutive patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 55 (2003) 892-898
23. Olivier K.R., Brown P.D., Stafford S.L., et al. Efficacy and treatment-related toxicity of radiotherapy for early-stage primary non-Hodgkin lymphoma of the parotid gland. Int J Radiat Oncol Biol Phys 60 (2004) 1510-1514
24. Zhou P., Ng A.K., Silver B., et al. Radiation therapy for orbital Lymphoma. Int J Radiat Oncol Biol Phys 3 (2005) 66-871
25. Wenzel C., Fiebiger W., Dieckmann K., et al. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of the head and neck area. Cancer 67 (2003) 2236-2241
26. Tsang R.W., Gospodarowicz M.K., Pintilie M., et al. Stages I and II MALT lymphoma: results of treatment with radiotherapy. Int J Radiat Oncol Biol Phys 50 (2001) 1258-1264
27. Hitchcock S., Ng A.K., Fisher D.C., et al. Treatment outcome of mucosa-associated lymphoid tissue/marginal zone non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 52 (2002) 1058-1066
28. Tsang R.W., Gospodarowicz M.K., Pintilie M., Wells W., Hodgson D.C., Sun A., et al. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent outcome. J Clin Oncol 21 (2003) 4157-4164
29. Schechter N.R., Portlock C.S., and Yahalom J. Treatment of mucosa associated lymphoid tissue lymphoma of the stomach with radiation alone. J Clin Oncol 16 (1998) 1916-1921
30. Fung C.Y., Grossbard M.L., Linggood R.M., et al. Mucosa-associated lymphoid tissue lymphoma of the stomach. Cancer 85 (1999) 9-17
31. Isobe K., Kagami Y., Higuchi K., Kodaira T., Hasegawa M., Shikama N., et al. Japan Radiation Oncology Group. A multicenter phase II study of local radiation therapy for stage IEA mucosa-associated lymphoid tissue lymphomas: a preliminary report from the Japan Radiation Oncology Group (JAROG). Int J Radiat Oncol Biol Phys 69 (2007) 1181-1186
32. Allal A., Kurtz J.M., Pipard G., Marti M.C., Miralbell R., Popowski Y., et al. Chemoradiotherapy versus radiotherapy alone for anal cancer: a retrospective comparison. Int J Radiat Oncol Biol Phys 27 (1993) 59-66
33. Esik O., Ikeda H., Mukai K., and Kaneko A. A retrospective analysis of different modalities for treatment of primary orbital non-Hodgkin's lymphomas. Radiother Oncol 38 (1996) 13-18
34. Sasai K., Yamabe H., Dodo Y., Kashii S., Nagata Y., and Hiraoka M. Non-Hodgkin's lymphoma of the ocular adnexa. Acta Oncol 40 (2001) 485-490
35. Lee J.L., Kim M.K., Lee K.H., Hyun M.S., Chung H.S., Kim D.S., et al. Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexa. Ann Hematol 84 (2005) 13-18
36. Jäger G., Neumeister P., Brezinschek R., Hinterleitner T., Fiebiger W., Penz M., et al. Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study. J Clin Oncol 20 (2002) 3872-3877
37. Zinzani P.L., Stefoni V., Musuraca G., Tani M., Alinari L., Gabriele A., et al. Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma. Cancer 100 (2004) 2190-2194
38. Taal B.G., Burgers J.M., van Heerde P., Hart A.A., and Somers R. The clinical spectrum and treatment of primary non-Hodgkin's lymphoma of the stomach. Ann Oncol 4 (1993) 839-846
39. Ruskoné-Fourmestraux A., Aegerter P., Delmer A., Brousse N., Galian A., and Rambaud J.C. Primary digestive tract lymphoma: a prospective multicentric study of 91 patients. Groupe d'Etude des Lymphomes Digestifs. Gastroenterology 105 (1993) 1662-1671
40. Hammel P., Haioun C., Chaumette M.T., Gaulard P., Divine M., Reyes F., et al. Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression. J Clin Oncol 13 (1995) 2524-2529
41. Conconi A., Martinelli G., Thiéblemont C., Ferreri A.J., Devizzi L., Peccatori F., et al. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 102 (2003) 2741-2745
42. Martinelli G., Laszlo D., Ferreri A.J., Pruneri G., Ponzoni M., Conconi A., et al. Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy. J Clin Oncol 23 (2005) 1979-1983
43. Zinzani P.L., Magagnoli M., Galieni P., Martelli M., Poletti V., Zaja F., et al. Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients. J Clin Oncol 17 (1999) 1254-1258
44. Arcaini L., Burcheri S., Rossi A., Passamonti F., Paulli M., Boveri E., et al. Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease dissemination. Oncologist 11 (2006) 285-291
45. Zucca E., Conconi A., Pedrinis E., Cortelazzo S., Motta T., Gospodarowicz M.K., et al. International Extranodal Lymphoma Study Group. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood 101 (2003) 2489-2495
46. Papaxoinis G, Fountzilas G, Rontogianni D, Dimopoulos MA, Pavlidis N, Tsatalas C, et al. Low-grade mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of 97 patients by the Hellenic Cooperative Oncology Group (HeCOG). Ann Oncol 2007 Dec 20. Epub ahead of print.
47. Conconi A., Bertoni F., Pedrinis E., Motta T., Roggero E., Luminari S., et al. Nodal marginal zone B-cell lymphomas may arise from different subsets of marginal zone B lymphocytes. Blood 98 (2001) 781-786
48. Jäger G., Neumeister P., Quehenberger F., Wöhrer S., Linkesch W., and Raderer M. Prolonged clinical remission in patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type treated with cladribine: 6 year follow-up of a phase II trial. Ann Oncol 17 (2006) 1722-1723
49. Pfeffer M.R., Rabin T., Tsvang L., Goffman J., Rosen N., and Symon Z. Orbital lymphoma: is it necessary to treat the entire orbit?. Int J Radiat Oncol Biol Phys 60 (2004) 527-530
50. Terai S., Iijima K., Kato K., Dairaku N., Suzuki T., Yoshida M., et al. Long-term outcomes of gastric mucosa-associated lymphoid tissue lymphomas after Helicobacter pylori eradication therapy. Tohoku J Exp Med 214 (2008) 79-87
51. Suh C.O., Shim S.J., Lee S.W., Yang W.I., Lee S.Y., and Hahn J.S. Orbital marginal zone B-cell lymphoma of MALT: radiotherapy results and clinical behavior. Int J Radiat Oncol Biol Phys 65 (2006) 228-233
52. Le Q.T., Eulau S.M., George T.I., Hildebrand R., Warnke R.A., Donaldson S.S., et al. Primary radiotherapy for localized orbital MALT lymphoma. Int J Radiat Oncol Biol Phys 52 (2002) 657-663
53. Zhou P., Ng A.K., Silver B., Li S., Hua L., and Mauch P.M. Radiation therapy for orbital lymphoma. Int J Radiat Oncol Biol Phys 63 (2005) 866-871